Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

Creston acquires DJM Digital Solutions

Deal includes 75 per cent of shares and an initial payment of £1.2m

Microsoft MedicineCabinet app aims to help patients recognise adverse events

Teams up with NextGen Healthcare on mobile personal medication record application

- PMLiVE

NICE backs Servier’s heart failure drug Procoralan

But recommendation includes a number of restrictions that limit NHS use of the drug

- PMLiVE

Gilead posts strong data for all-oral hepatitis C treatment

Achieves sustained virologic response in 78 per cent of participants

- PMLiVE

Bayer’s eye drug Eylea approved in Europe

Will compete with Novartis' Lucentis in wet AMD

- PMLiVE

Acadia shares increase as pimavanserin clears phase III trial

Demonstrated to reduce psychotic symptoms

Zogenix appoints Pfizer’s R Scott Shively as chief commercial officer

Was VP global commercial disease area lead for pain at Pfizer

Sandra Rafferty: ‘If I could change one thing…’

The Business Development Director at Apodi explains what she would improve within the industry

- PMLiVE

EMA publishes drug shortages plan

Globalisation of manufacturing among key issues to address

- PMLiVE

European approval for Abbott’s Humira in children with Crohn’s disease

Adds to existing autoimmune indications for company’s top-selling drug

- PMLiVE

Novartis calls for improvements to UK clinical trial system

Says cost of running studies in the country undermines its attractiveness

german flag

Pharma industry challenges Germany’s drug pricing policy

Says mandatory discounts and price freezes on drugs are no longer justified

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links